Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072745
Filing Date
2025-05-15
Accepted
2025-05-15 16:31:08
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hura-20250331.htm   iXBRL 10-Q 1467943
2 EX-31.1 hura-ex31_1.htm EX-31.1 17605
3 EX-31.2 hura-ex31_2.htm EX-31.2 17599
4 EX-32.1 hura-ex32_1.htm EX-32.1 9919
5 EX-32.2 hura-ex32_2.htm EX-32.2 9843
  Complete submission text file 0000950170-25-072745.txt   6971631

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250331.xsd EX-101.SCH 1752509
70 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250331_htm.xml XML 759310
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 25954159
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)